These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 27027552)
1. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line. Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552 [TBL] [Abstract][Full Text] [Related]
2. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600 [TBL] [Abstract][Full Text] [Related]
3. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells. Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866 [TBL] [Abstract][Full Text] [Related]
4. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid. Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429 [TBL] [Abstract][Full Text] [Related]
5. PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem. Jafarizad A; Taghizadehgh-Alehjougi A; Eskandani M; Hatamzadeh M; Abbasian M; Mohammad-Rezaei R; Mohammadzadeh M; Toğar B; Jaymand M Biomed Mater Eng; 2018; 29(2):177-190. PubMed ID: 29457592 [TBL] [Abstract][Full Text] [Related]
6. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy. Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088 [TBL] [Abstract][Full Text] [Related]
7. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery. Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243 [TBL] [Abstract][Full Text] [Related]
8. The Structure-Dependent Electric Release and Enhanced Oxidation of Drug in Graphene Oxide-Based Nanocarrier Loaded with Anticancer Herbal Drug Berberine. Yu D; Ruan P; Meng Z; Zhou J J Pharm Sci; 2015 Aug; 104(8):2489-500. PubMed ID: 26052932 [TBL] [Abstract][Full Text] [Related]
9. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123 [TBL] [Abstract][Full Text] [Related]
10. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines. Tas A; Keklikcioglu Cakmak N Hum Exp Toxicol; 2021 Jan; 40(1):172-182. PubMed ID: 32909849 [TBL] [Abstract][Full Text] [Related]
12. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma. Li G; Yang Y; Zhou R; Meng F; Li X Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404 [TBL] [Abstract][Full Text] [Related]
13. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419 [TBL] [Abstract][Full Text] [Related]
14. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier. Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of PEGylated graphene oxide on lymphoma cells. Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911 [TBL] [Abstract][Full Text] [Related]
16. A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets. Masoudipour E; Kashanian S; Maleki N; Karamyan A; Omidfar K Drug Dev Ind Pharm; 2018 Jan; 44(1):99-108. PubMed ID: 28956455 [TBL] [Abstract][Full Text] [Related]
17. Functionalized graphene oxides for drug loading, release and delivery of poorly water soluble anticancer drug: A comparative study. Karki N; Tiwari H; Pal M; Chaurasia A; Bal R; Joshi P; Sahoo NG Colloids Surf B Biointerfaces; 2018 Sep; 169():265-272. PubMed ID: 29783152 [TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
19. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Zhao X; Yang L; Li X; Jia X; Liu L; Zeng J; Guo J; Liu P Bioconjug Chem; 2015 Jan; 26(1):128-36. PubMed ID: 25525819 [TBL] [Abstract][Full Text] [Related]
20. Preparation of hollow core/shell Fe Wang J; Fang J; Fang P; Li X; Wu S; Zhang W; Li S J Biomater Sci Polym Ed; 2017 Mar; 28(4):337-349. PubMed ID: 27931160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]